These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6714536)

  • 1. The complement component C4 in black Americans with type 1 (insulin-dependent) diabetes mellitus.
    Budowle B; Roseman JM; Go RC; Barger BO; Acton RT
    Diabetologia; 1984 Feb; 26(2):166-8. PubMed ID: 6714536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypes of the fourth complement component (C4) in black Americans from the southeastern United States.
    Budowle B; Roseman JM; Go RC; Louv W; Barger BO; Acton RT
    J Immunogenet; 1983 Jun; 10(3):199-203. PubMed ID: 6875279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and antigenic differences in complement component C4 between American blacks and whites.
    Moulds JM; Warner NB; Arnett FC
    Complement Inflamm; 1991; 8(5-6):281-7. PubMed ID: 1802546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C4 null genes in American whites and blacks with myositis.
    Moulds JM; Rolih C; Goldstein R; Whittington KF; Warner NB; Targoff IN; Reichlin M; Arnett FC
    J Rheumatol; 1990 Mar; 17(3):331-4. PubMed ID: 2332854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C4 and Bf phenotypes in black and Caucasian patients with childhood onset insulin dependent diabetes mellitus.
    Wang C; Rivas ML; Burghen GA; Hudson EC; Wyatt RJ
    J Clin Lab Immunol; 1989 Dec; 30(4):183-90. PubMed ID: 2642174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls.
    Bertrams J; Hintzen U; Schlicht V; Schoeps S; Gries FA; Louton TK; Baur MP
    Immunobiology; 1984 May; 166(4-5):335-44. PubMed ID: 6480029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular heterogeneity of complement component C4-null and 21-hydroxylase genes in systemic lupus erythematosus.
    Goldstein R; Arnett FC; McLean RH; Bias WB; Duvic M
    Arthritis Rheum; 1988 Jun; 31(6):736-44. PubMed ID: 3260100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans.
    Howard PF; Hochberg MC; Bias WB; Arnett FC; McLean RH
    Am J Med; 1986 Aug; 81(2):187-93. PubMed ID: 3461713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of gene expression (allotypes) of the fourth component of complement to insulin dependent diabetes and its microangiopathic complications.
    Mijovic C; Fletcher J; Bradwell AR; Harvey T; Barnett AH
    Br Med J (Clin Res Ed); 1985 Jul; 291(6487):9-10. PubMed ID: 3926068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
    Skanes V; Larsen B; Sampson-Murphy L; Farid NR
    Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus.
    Olsen ML; Goldstein R; Arnett FC; Duvic M; Pollack M; Reveille JD
    Immunogenetics; 1989; 30(1):27-33. PubMed ID: 2568334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An estimate on the frequency of duplicated haplotypes and silent alleles of human C4 protein polymorphism. II. Investigations in healthy Negro families.
    Steuer MK; Oudshoorn M; Brenden M; Fimmers R; Neugebauer M; du Toit E; Baur MP; Mauff G
    Tissue Antigens; 1994 Feb; 43(2):88-94. PubMed ID: 8016847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement component C4A and C4B levels in systemic lupus erythematosus: quantitation in relation to C4 null status and disease activity.
    Moulds JM; Warner NB; Arnett FC
    J Rheumatol; 1993 Mar; 20(3):443-7. PubMed ID: 8478849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique recombination event resulting in a C4A*Q0,C4B*Q0 double null haplotype.
    Fasano MB; Winkelstein JA; LaRosa T; Bias WB; McLean RH
    J Clin Invest; 1992 Oct; 90(4):1180-4. PubMed ID: 1401055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo.
    Venneker GT; Westerhof W; de Vries IJ; Drayer NM; Wolthers BG; de Waal LP; Bos JD; Asghar SS
    J Invest Dermatol; 1992 Dec; 99(6):853-8. PubMed ID: 1469300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intricate role of complement component C4 in human systemic lupus erythematosus.
    Yang Y; Chung EK; Zhou B; Lhotta K; Hebert LA; Birmingham DJ; Rovin BH; Yu CY
    Curr Dir Autoimmun; 2004; 7():98-132. PubMed ID: 14719377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiolipin antibodies and null alleles of C4 in black Americans with systemic lupus erythematosus.
    Wilson WA; Perez MC; Michalski JP; Armatis PE
    J Rheumatol; 1988 Dec; 15(12):1768-72. PubMed ID: 3265959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism of the fourth component of complement and type 1 (insulin-dependent) diabetes.
    Marcelli-Barge A; Poirier JC; Schmid M; Deschamps I; Lestradet H; Prevost P; Hors J
    Diabetologia; 1984 Jul; 27 Suppl():116-7. PubMed ID: 6332752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional variation in C4 phenotype in patients with IgA nephropathy.
    Wyatt RJ; Rivas ML; Schena FP; Bin JA; Julian BA
    J Pediatr; 1990 May; 116(5):S72-7. PubMed ID: 2329414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.